IGI receives CIRM Inception Award to study mechanisms in blood cancers

The IGI has been awarded a CIRM Inception Award to use gene editing in bone marrow stem cells in order to discover mechanisms that lead to certain types of blood cancers.  The CIRM Inception Awards provide seed funding to support the exploration of transformational ideas that hold the potential to greatly impact the field of human stem cell research.  The IGI will use genetic engineering to determine how mutations frequently observed in the bone marrow stem cells of patients lead to a family of diseases called meyloproliferative neoplasms (MPNs).  The MPN disorders are characterized by over-production of certain blood cells, such as red blood cells or platelets, but it is unclear how patient mutations cause these disorders.  A better understanding of how MPN-associated mutations lead to disease could eventually lead to better therapies for patients suffering from MPN.

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

March 4, 2021

Welcome to Sebastian

Sebastian joined the Corn lab as a PhD student in March 2021. He received his MSc in Biochemistry from ETH Zurich in December 2020 with his work on the therapeutic...

March 3, 2021

PnB Designer – fast help with prime and base editing

The Coronavirus lockdowns this spring disrupted many projects and students. But when life gives you lemons, make lemonade. In our lab, almost everyone took...

January 14, 2021

Congratulations to Mandy on the ETH Pioneer Fellowship

Mandy has just been awarded the Pioneer Fellowship which will allow her to transform her fundamental research into a startup focused on new treatments for ...

News Archive

Tweets